CN100537596C - 制备动物胎盘兽用复方氨基酸口服液的方法 - Google Patents
制备动物胎盘兽用复方氨基酸口服液的方法 Download PDFInfo
- Publication number
- CN100537596C CN100537596C CNB2006101460667A CN200610146066A CN100537596C CN 100537596 C CN100537596 C CN 100537596C CN B2006101460667 A CNB2006101460667 A CN B2006101460667A CN 200610146066 A CN200610146066 A CN 200610146066A CN 100537596 C CN100537596 C CN 100537596C
- Authority
- CN
- China
- Prior art keywords
- placenta
- amino acid
- cracking
- liquid
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 210000002826 placenta Anatomy 0.000 title claims abstract description 26
- 241001465754 Metazoa Species 0.000 title claims abstract description 15
- 239000007788 liquid Substances 0.000 title claims description 27
- -1 compound amino acid Chemical class 0.000 title claims description 8
- 150000001413 amino acids Chemical class 0.000 claims abstract description 50
- 238000005336 cracking Methods 0.000 claims abstract description 20
- 238000010306 acid treatment Methods 0.000 claims abstract description 12
- 238000012856 packing Methods 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 238000000926 separation method Methods 0.000 claims abstract description 3
- 235000001014 amino acid Nutrition 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 13
- 210000005059 placental tissue Anatomy 0.000 claims description 12
- 230000002378 acidificating effect Effects 0.000 claims description 9
- 238000004945 emulsification Methods 0.000 claims description 8
- 206010018910 Haemolysis Diseases 0.000 claims description 6
- 210000001691 amnion Anatomy 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 230000008588 hemolysis Effects 0.000 claims description 6
- 230000008676 import Effects 0.000 claims description 6
- 239000006185 dispersion Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 210000001136 chorion Anatomy 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 239000010408 film Substances 0.000 claims description 4
- 238000002203 pretreatment Methods 0.000 claims description 4
- 238000001223 reverse osmosis Methods 0.000 claims description 4
- 230000002000 scavenging effect Effects 0.000 claims description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 239000003729 cation exchange resin Substances 0.000 claims description 3
- 230000003749 cleanliness Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 2
- 210000003711 chorioallantoic membrane Anatomy 0.000 claims description 2
- 210000004252 chorionic villi Anatomy 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 235000014666 liquid concentrate Nutrition 0.000 claims description 2
- 239000006166 lysate Substances 0.000 claims description 2
- 229920002521 macromolecule Polymers 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical group C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 16
- 102000004190 Enzymes Human genes 0.000 abstract description 11
- 108090000790 Enzymes Proteins 0.000 abstract description 11
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 239000002253 acid Substances 0.000 abstract description 5
- 241001494479 Pecora Species 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 2
- 241000700605 Viruses Species 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 230000001804 emulsifying effect Effects 0.000 abstract 1
- 238000007493 shaping process Methods 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 description 46
- 230000007062 hydrolysis Effects 0.000 description 14
- 238000006460 hydrolysis reaction Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- 238000005903 acid hydrolysis reaction Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 108010001515 Galectin 4 Proteins 0.000 description 3
- 102100039556 Galectin-4 Human genes 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 239000006035 Tryptophane Substances 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 238000012407 engineering method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006340 racemization Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 101710158668 Placental protein Proteins 0.000 description 1
- 102000008217 Pregnancy Proteins Human genes 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101460667A CN100537596C (zh) | 2006-11-07 | 2006-11-07 | 制备动物胎盘兽用复方氨基酸口服液的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101460667A CN100537596C (zh) | 2006-11-07 | 2006-11-07 | 制备动物胎盘兽用复方氨基酸口服液的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1965863A CN1965863A (zh) | 2007-05-23 |
CN100537596C true CN100537596C (zh) | 2009-09-09 |
Family
ID=38074956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101460667A Expired - Fee Related CN100537596C (zh) | 2006-11-07 | 2006-11-07 | 制备动物胎盘兽用复方氨基酸口服液的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100537596C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107674865B (zh) * | 2017-11-20 | 2021-04-20 | 西藏天慈生物科技有限公司 | 一种提取动物胎盘中的酶的方法 |
CN108142939A (zh) * | 2018-02-05 | 2018-06-12 | 内蒙古康肽生物工程有限公司 | 一种含胎盘干细胞因子的口服液及其制备方法 |
CN114306221A (zh) * | 2021-12-07 | 2022-04-12 | 北京生泰尔科技股份有限公司 | 一种兽用羊胎盘复方氨基酸口服液及其制备方法 |
-
2006
- 2006-11-07 CN CNB2006101460667A patent/CN100537596C/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
羊胎盘素提取新工艺及其营养成分的分析测定. 乌云.食品科学,第26卷第9期. 2005 |
羊胎盘素提取新工艺及其营养成分的分析测定. 乌云.食品科学,第26卷第9期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1965863A (zh) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104531817B (zh) | 一种透明质酸、硫酸软骨素、胶原蛋白肽、骨粉饲料和肥皂联产的方法 | |
CN101643767B (zh) | 一种从杏仁粕中制备杏仁肽的方法 | |
US5428016A (en) | Antimicrobial peptide and antimicrobial agent | |
CN101263860B (zh) | 从牡蛎粉中酶法制取牡蛎肽的工业生产方法 | |
CN101886106A (zh) | 一种鱼鳞胶原蛋白肽的提取方法 | |
CN102551111A (zh) | 鱼骨有机酸钙多肽粉的制备方法 | |
US20050148049A1 (en) | Proteolytic fermenter | |
CN110495611A (zh) | 一种提高海参营养保健功效的工艺 | |
CN104402972A (zh) | 一种海参抗氧化多肽及其制备方法 | |
CN101544965B (zh) | 从猪胎盘中提取多种生物活性物质的联产工艺 | |
CN102321719A (zh) | 一种鱼鳞中酶法制取胶原蛋白的工业生产方法 | |
CN100537596C (zh) | 制备动物胎盘兽用复方氨基酸口服液的方法 | |
CN104610430A (zh) | 利用灵芝蛋白制备的抗氧化多肽及其制备方法 | |
CN1891711A (zh) | 鹿胎盘生理活性多肽的制备方法 | |
US20040038391A1 (en) | Amino acids factory | |
JP5399468B2 (ja) | 脂肪分解活性を呈する組成物 | |
CN109439716A (zh) | 一种白鲢鱼蛋白肽的制备方法 | |
CN102277403B (zh) | 酶法提取黄酒糟蛋白生产工艺 | |
KR20120081454A (ko) | 발효 콜라겐의 제조방법 | |
CN108740664A (zh) | 一种大豆肽固体饮料及其制备工艺 | |
CN104650191A (zh) | 一种利用紫菜蛋白制备的抗氧化多肽及其制作方法 | |
CN207136152U (zh) | 一种核桃低聚肽与大枣多糖的复合物的生产系统 | |
CN1046351A (zh) | 蚯蚓的酶工程技术 | |
CN1232264C (zh) | 低温超声波高压蛋白裂解法制取羊胎盘生物制剂的技术 | |
CN103215314A (zh) | 一种鱼鳞经双菌种多酶系发酵生产护肤品原料的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20160901 Granted publication date: 20090909 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170301 Granted publication date: 20090909 |
|
PP01 | Preservation of patent right |
Effective date of registration: 20170303 Granted publication date: 20090909 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170903 Granted publication date: 20090909 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing compound amino acid oral liquid by using animals placenta Effective date of registration: 20180703 Granted publication date: 20090909 Pledgee: Zhang Yongping Pledgor: Inner Mongolia Shenyuan Genetic Engineering Co., Ltd. Registration number: 2018990000521 |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Inner Mongolia Shenyuan Genetic Engineering Co., Ltd. Document name: Notification of Termination of Patent Right |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090909 Termination date: 20181107 |